Paper41102401
Impact of Wilms' tumor 1 gene (WT1) mutation on outcome of allogeneic hematopoietic-cell transplantation for acute myeloid leukemia: a retrospective multicenter cohort study from the ALWP/EBMT registry.
Nagler A and 20 others. Bone Marrow Transplant, 2026. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Impact of Wilms' tumor 1 gene (WT1) mutation on outcome of allogeneic hematopoietic-cell transplantation for acute myeloid leukemia: a retrospective multicenter cohort study from the ALWP/EBMT registry. Papers, record 41102401. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41102401
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
Impact of Wilms' tumor 1 gene (WT1) mutation on outcome of allogeneic hematopoietic-cell transplantation for acute myeloid leukemia: a retrospective multicenter cohort study from the ALWP/EBMT registry.
- PubMed
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Leukemia, Myeloid, Acute | Major topic |
| Hematopoietic Stem Cell Transplantation | Major topic |
| Mutation | Major topic |
| WT1 Proteins | Major topic |
| Transplantation Conditioning | Major topic |
| Humans | |
| Female | |
| Male | |
| Middle Aged | |
| Adult | |
| Retrospective Studies | |
| Registries | |
| Aged | |
| Transplantation, Homologous | |
| Treatment Outcome | |
| Adolescent | |
| Young Adult | |
| Allografts |
Source PubMed
References33
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35797463 | Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN. | Blood | 2022 | https://conductscience.org/library/papers/35797463 | PubMed |
| 2 | 6996481 | Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. | Am J Med | 1980 | https://conductscience.org/library/papers/6996481 | PubMed |
| 3 | 7581076 | 1994 Consensus Conference on Acute GVHD Grading. | Bone Marrow Transplant | 1995 | https://conductscience.org/library/papers/7581076 | PubMed |
| 4 | 20413658 | Prevalence and prognostic implications of WT1 mutations in pediatric acute myeloid leukemia (AML): a report from the Children's Oncology Group. | Blood | 2010 | https://conductscience.org/library/papers/20413658 | PubMed |
| 5 | 19536888 | Wilms tumor 1 gene mutations are associated with a higher risk of recurrence in young adults with acute myeloid leukemia: a study from the Acute Leukemia French Association. | Cancer | 2009 | https://conductscience.org/library/papers/19536888 | PubMed |
| 6 | 34595436 | Summary of Scientific and Statistical Methods, Study Endpoints and Definitions for Observational and Registry-Based Studies in Hematopoietic Cell Transplantation. | Clin Hematol Int | 2020 | https://conductscience.org/library/papers/34595436 | PubMed |
| 7 | 31350825 | Uncovering the Genomic Landscape in Newly Diagnosed and Relapsed Pediatric Cytogenetically Normal FLT3-ITD AML. | Clin Transl Sci | 2019 | https://conductscience.org/library/papers/31350825 | PubMed |
| 8 | 19752335 | Real-time quantitative polymerase chain reaction detection of minimal residual disease by standardized WT1 assay to enhance risk stratification in acute myeloid leukemia: a European LeukemiaNet study. | J Clin Oncol | 2009 | https://conductscience.org/library/papers/19752335 | PubMed |
| 9 | 34670359 | Tumor suppressor function of WT1 in acute promyelocytic leukemia. | Haematologica | 2022 | https://conductscience.org/library/papers/34670359 | PubMed |
| 10 | 27895058 | Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. | Blood | 2017 | https://conductscience.org/library/papers/27895058 | PubMed |
| 11 | 39133932 | Genetic risk classification for adults with AML receiving less-intensive therapies: the 2024 ELN recommendations. | Blood | 2024 | https://conductscience.org/library/papers/39133932 | PubMed |
| 12 | 37366878 | Novel Tools for Diagnosis and Monitoring of AML. | Curr Oncol | 2023 | https://conductscience.org/library/papers/37366878 | PubMed |
| 13 | 38031921 | Clinical significance of WT1 in the evaluation of therapeutic effect and prognosis of non-M3 acute myeloid leukemia. | Cancer Biol Ther | 2023 | https://conductscience.org/library/papers/38031921 | PubMed |
| 14 | 36823396 | Outcome prediction by the 2022 European LeukemiaNet genetic-risk classification for adults with acute myeloid leukemia: an Alliance study. | Leukemia | 2023 | https://conductscience.org/library/papers/36823396 | PubMed |
| 15 | 10398287 | Testing for centre effects in multi-centre survival studies: a Monte Carlo comparison of fixed and random effects tests. | Stat Med | 1999 | https://conductscience.org/library/papers/10398287 | PubMed |
| 16 | 29296935 | Mutational analysis of disease relapse in patients allografted for acute myeloid leukemia. | Blood Adv | 2016 | https://conductscience.org/library/papers/29296935 | PubMed |
| 17 | 32019476 | Clinical features and prognosis of normal karyotype acute myeloid leukemia pediatric patients with WT1 mutations: an analysis based on TCGA database. | Hematology | 2020 | https://conductscience.org/library/papers/32019476 | PubMed |
| 18 | 18591546 | Mutation of the Wilms' tumor 1 gene is a poor prognostic factor associated with chemotherapy resistance in normal karyotype acute myeloid leukemia: the United Kingdom Medical Research Council Adult Leukaemia Working Party. | J Clin Oncol | 2008 | https://conductscience.org/library/papers/18591546 | PubMed |
| 19 | 39207267 | WT1 and DNMT3A Mutations in Prognostic Significance of Acute Myeloid Leukemia: A Meta-Analysis. | Cancer Biother Radiopharm | 2025 | https://conductscience.org/library/papers/39207267 | PubMed |
| 20 | 19221039 | Prognostic impact of WT1 mutations in cytogenetically normal acute myeloid leukemia: a study of the German-Austrian AML Study Group. | Blood | 2009 | https://conductscience.org/library/papers/19221039 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 41537901 | Next-generation CAR-T therapy for acute myeloid leukemia: bridging innovation with clinical translation. | Ann Hematol | 2026 | https://conductscience.org/library/papers/41537901 |
Source PubMed
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CR1 | 1378 | PubTator's text mining | https://conductscience.org/library/genes/1378 | NCBI Gene |
| FLT3 | 2322 | PubTator's text mining | https://conductscience.org/library/genes/2322 | NCBI Gene |
| WT1 | 7490 | PubTator's text mining | https://conductscience.org/library/genes/7490 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41102401
GET https://conductscience.org/api/papers/v1/41102401/authors?page=2